Applied Molecular Transport (AMT) is a biopharmaceutical company with a transformative platform technology that enables the development of next generation biological therapeutics, with a particular focus on oral, site-specific targeting to the GI tract as well as to systemic circulation. The company’s core pipeline therapeutic area strategy is focused on Immunology & Inflammation and Metabolic Diseases.
This role is a unique opportunity in an energetic company that is based on exciting foundational scientific principles with the prospect of transforming the biological therapeutics landscape and thus, beneficially impacting the lives of millions of patients. The company’s management and founders collectively have decades of R&D, business, and leadership experience at organizations such as Amgen, Chiron, Onyx, ALZA, Five Prime, Second Genome, NGM and Genentech.
Copyright © APPLIED MOLECULAR TRANSPORT, LLC 2016. All rights reserved.